Cost-effectiveness of apixaban, dabigatran, rivaroxaban, and warfarin for stroke prevention in atrial fibrillation
AR Harrington, EP Armstrong, PE Nolan Jr, DC Malone - Stroke, 2013 - Am Heart Assoc
Background and Purpose—To estimate the cost-effectiveness of stroke prevention in
patients with nonvalvular atrial fibrillation by using novel oral anticoagulants apixaban 5 mg …
patients with nonvalvular atrial fibrillation by using novel oral anticoagulants apixaban 5 mg …
Is fidaxomicin worth the cost? An economic analysis
SM Bartsch, CA Umscheid, N Fishman… - Clinical infectious …, 2013 - academic.oup.com
Abstract Background. In May 2011, the Food and Drug Administration approved fidaxomicin
for the treatment of Clostridium difficile infection (CDI). It has been found to be noninferior to …
for the treatment of Clostridium difficile infection (CDI). It has been found to be noninferior to …
Impact of a patient-centered pharmacy program and intervention in a high-risk group
JM Moore, D Shartle, L Faudskar, OS Matlin… - Journal of Managed …, 2013 - jmcp.org
BACKGROUND: The medication therapy management (MTM) program identified high-risk
members in a large employer group and invited them to participate in an MTM program. The …
members in a large employer group and invited them to participate in an MTM program. The …
The cost-effectiveness of temozolomide in the adjuvant treatment of newly diagnosed glioblastoma in the United States
A Messali, JW Hay, R Villacorta - Neuro-oncology, 2013 - academic.oup.com
Background The objective of this work was to determine the cost-effectiveness of
temozolomide compared with that of radiotherapy alone in the adjuvant treatment of newly …
temozolomide compared with that of radiotherapy alone in the adjuvant treatment of newly …
Feasibility of venous thromboembolism prophylaxis during inflammatory bowel disease flares in the outpatient setting: a decision analysis
GC Nguyen, S Sharma - Inflammatory bowel diseases, 2013 - academic.oup.com
Background Inflammatory bowel disease (IBD) patients are at increased risk of venous
thromboembolism (VTE), which is most pronounced during a disease flare. We explored the …
thromboembolism (VTE), which is most pronounced during a disease flare. We explored the …
Is selective lymphadenectomy more cost-effective than routine lymphadenectomy in patients with endometrial cancer?
AE Clements, BJ Tierney, DE Cohn… - Gynecologic oncology, 2013 - Elsevier
OBJECTIVE: The objective of this study is to determine the cost-effectiveness of two
strategies in women undergoing surgery for newly diagnosed endometrial cancer …
strategies in women undergoing surgery for newly diagnosed endometrial cancer …
Examining the link between cash flow, market value, and research and development investment spending in the medical device industry
BP Schmutz, RE Santerre - Health Economics, 2013 - Wiley Online Library
Unlike the pharmaceutical industry, no empirical research has focused on the factors
influencing research and development (R&D) spending in the medical device industry. To fill …
influencing research and development (R&D) spending in the medical device industry. To fill …
[HTML][HTML] Cost-effectiveness analysis comparing robotic sacrocolpopexy to a vaginal mesh hysteropexy for treatment of uterovaginal prolapse
PJ Culligan, C Salamon, C Lewis, TD Abell - Open Journal of Obstetrics …, 2013 - scirp.org
Objective: To compare costs and QoL associated with 2 minimally invasive operations to
treat uterovaginal prolapse. Study Design: A decision analytic cost-effectiveness model …
treat uterovaginal prolapse. Study Design: A decision analytic cost-effectiveness model …
Evaluating the Utility of Clinical Criteria for the Identification of Lynch Syndrome among Endometrial Cancer Patients
AS Bruegl - 2013 - digitalcommons.library.tmc.edu
Background: Lynch Syndrome (LS) is a familial cancer syndrome with a high prevalence of
colorectal and endometrial carcinomas among affected family members. Clinical criteria …
colorectal and endometrial carcinomas among affected family members. Clinical criteria …
[图书][B] Optimal Information Collection for Dynamic Health Care Policy
LE Cipriano - 2013 - search.proquest.com
Mathematical models of health systems and disease can provide important information to
decision makers when direct experimentation is impossible, impractical, or unethical, and …
decision makers when direct experimentation is impossible, impractical, or unethical, and …